UK markets closed

Freeline Therapeutics Holdings plc (FRLN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.9600+0.0480 (+5.26%)
As of 03:03PM EDT. Market open.
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
0
0
0
0
0
Operating expenses
Research development
91,516
95,431
76,149
47,043
34,191
Selling general and administrative
42,713
44,568
26,300
16,601
6,790
Total operating expenses
132,350
137,908
87,180
53,049
32,715
Operating income or loss
-132,350
-137,908
-87,180
-53,049
-32,715
Interest expense
-
-
-
-
151
Total other income/expenses net
177
-2,546
-9,288
-793
-390
Income before tax
-131,824
-140,049
-96,193
-53,768
-33,256
Income tax expense
355
342
129
141
27
Income from continuing operations
-132,179
-140,391
-96,322
-53,909
-33,283
Net income
-132,179
-140,391
-96,322
-53,909
-33,283
Net income available to common shareholders
-132,179
-140,391
-96,322
-53,909
-33,283
Basic EPS
-
-3.93
-6.81
-2.52
-5.24
Diluted EPS
-
-3.93
-6.81
-2.52
-5.24
Basic average shares
-
35,704
14,153
21,351
6,348
Diluted average shares
-
35,704
14,153
21,351
6,348
EBITDA
-
-135,518
-85,267
-51,509
-32,135